Showing results (1-10 of 643) with videos related to
Sort By:
Pageof 65
Journal of the National Cancer Institute|September 15, 1993
Natural killer cells and bone marrow transplantationW J Murphy, C W Reynolds, P Tiberghien, et al.Blood|October 1, 1990
Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recoveryP Tiberghien, D L Longo, J W Wine, et al.Blood|October 15, 1993
Activated natural killer cells and interleukin-2 promote granulocytic and megakaryocytic reconstitution after syngeneic bone marrow transplantation in miceA K Siefer, D L Longo, C L Harrison, et al.Journal of the National Cancer Institute|August 5, 1992
Hematopoietic growth-promoting effects of natural killer cells in mice in response to in vivo administration of human interleukin-2W J Murphy, D L LongoImmunological Reviews|June 1, 1997
The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantationW J Murphy, D L LongoJournal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|March 1, 1996
Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomasS Funakoshi, D L Longo, W J MurphyExperimental Hematology|December 1, 1994
Human insulin-like growth factor I exerts hematopoietic growth-promoting effects after in vivo administrationG Tsarfaty, D L Longo, W J MurphyLife Sciences|January 1, 1995
Effects of growth hormone and prolactin immune development and functionW J Murphy, H Rui, D L LongoBlood|September 15, 1992
Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidineW J Murphy, G Tsarfaty, D L LongoBlood|August 15, 1994
Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?P Tiberghien, C W Reynolds, J Keller, et al.Pageof 65